The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

Here’s another clue to who might be more vulnerable than others to long Covid. A new study published Wednesday in PLOS has ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

Cardiovascular issues are common, and now some experts term severe COVID an independent coronary artery disease risk factor ...

A nationally representative U.S. study of over 100,000 adults found that post-COVID conditions (PCCs) significantly reduce ...